跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
CSL US AlbuRx 25 Albumin (Human) 25% solution - TGA Drug Approval Details
Approvals
/
TGA
/
CSL US AlbuRx 25 Albumin (Human) 25% solution
Approved
STANDARD
CSL US AlbuRx 25 Albumin (Human) 25% solution
CSL Behring (Australia) Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 30, 2025
Approval ID
49ec854210522224
Company
CSL Behring (Australia) Pty Ltd
Type
Standard
Approval Details
Approval Id
49ec854210522224
Product Name
CSL US AlbuRx 25 Albumin (Human) 25% solution
Artg Id
383957
Artg Name
CSL US AlbuRx 25 Albumin (Human) 25% solution
Sponsor
CSL Behring (Australia) Pty Ltd
Company Detail Path
/organization/csl-behring-australia-pty-ltd
Artg Date
2022-02-14
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
LIE
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 30, 2025
Approval ID
49ec854210522224
Type
Standard
Back to TGA Approvals
